Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Source: CNBC Markets ·
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Read the full story at CNBC Markets
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.